Prokineticin-2 upregulation during neuronal injury mediates a compensatory protective response against dopaminergic neuronal degeneration
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prokineticin-2 upregulation during neuronal injury mediates a compensatory protective response against dopaminergic neuronal degeneration
Authors
Keywords
-
Journal
Nature Communications
Volume 7, Issue -, Pages 12932
Publisher
Springer Nature
Online
2016-10-05
DOI
10.1038/ncomms12932
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Sirtuin-2 Inhibitor AK7 Is Neuroprotective in Models of Parkinson’s Disease but Not Amyotrophic Lateral Sclerosis and Cerebral Ischemia
- (2015) Xiqun Chen et al. PLoS One
- Axon degeneration and PGC-1 -mediated protection in a zebrafish model of -synuclein toxicity
- (2014) K. C. O'Donnell et al. Disease Models & Mechanisms
- Role of proteolytic activation of protein kinase Cδ in the pathogenesis of prion disease
- (2014) Dilshan S Harischandra et al. Prion
- Novel Para-Phenyl Substituted Diindolylmethanes Protect Against MPTP Neurotoxicity and Suppress Glial Activation in a Mouse Model of Parkinson’s Disease
- (2014) Briana R. De Miranda et al. TOXICOLOGICAL SCIENCES
- The Peptidyl-prolyl Isomerase Pin1 Up-regulation and Proapoptotic Function in Dopaminergic Neurons
- (2013) Anamitra Ghosh et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- G-protein-coupled Receptor Agonist BV8/Prokineticin-2 and STAT3 Protein Form a Feed-forward Loop in Both Normal and Malignant Myeloid Cells
- (2013) Hong Xin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Vanadium exposure induces olfactory dysfunction in an animal model of metal neurotoxicity
- (2013) Hilary Afeseh Ngwa et al. NEUROTOXICOLOGY
- A PK2/Bv8/PROK2 Antagonist Suppresses Tumorigenic Processes by Inhibiting Angiogenesis in Glioma and Blocking Myeloid Cell Infiltration in Pancreatic Cancer
- (2013) Valerie F. Curtis et al. PLoS One
- Proteolytic activation of proapoptotic kinase protein kinase Cδ by tumor necrosis factor α death receptor signaling in dopaminergic neurons during neuroinflammation
- (2012) Richard Gordon et al. Journal of Neuroinflammation
- Impact of intravenous immunoglobulin on the dopaminergic system and immune response in the acute MPTP mouse model of Parkinson’s disease
- (2012) Isabelle St-Amour et al. Journal of Neuroinflammation
- Anti-inflammatory and neuroprotective effects of an orally active apocynin derivative in pre-clinical models of Parkinson’s disease
- (2012) Anamitra Ghosh et al. Journal of Neuroinflammation
- Sodium Phenylbutyrate Controls Neuroinflammatory and Antioxidant Activities and Protects Dopaminergic Neurons in Mouse Models of Parkinson’s Disease
- (2012) Avik Roy et al. PLoS One
- Prokineticin 2 is an endangering mediator of cerebral ischemic injury
- (2012) M. Y. Cheng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prokineticin 2 is involved in the thermoregulation and energy expenditure
- (2012) Wenbai Zhou et al. REGULATORY PEPTIDES
- Transgenic expression and activation of PGC-1α protect dopaminergic neurons in the MPTP mouse model of Parkinson’s disease
- (2011) Giuseppa Mudò et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- The Role of the Prokineticin 2 Pathway in Human Reproduction: Evidence from the Study of Human and Murine Gene Mutations
- (2011) Cecilia Martin et al. ENDOCRINE REVIEWS
- Resistance to MPTP-Neurotoxicity in α-Synuclein Knockout Mice Is Complemented by Human α-Synuclein and Associated with Increased β-Synuclein and Akt Activation
- (2011) Bobby Thomas et al. PLoS One
- Dopaminergic neurotoxicant 6-OHDA induces oxidative damage through proteolytic activation of PKCδ in cell culture and animal models of Parkinson's disease
- (2011) Calivarathan Latchoumycandane et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Mechanism of Neuroprotective Mitochondrial Remodeling by PKA/AKAP1
- (2011) Ronald A. Merrill et al. PLOS BIOLOGY
- Neuroprotection by a mitochondria-targeted drug in a Parkinson's disease model
- (2010) Anamitra Ghosh et al. FREE RADICAL BIOLOGY AND MEDICINE
- A Small Molecule Inhibits Akt through Direct Binding to Akt and Preventing Akt Membrane Translocation
- (2010) Donghwa Kim et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- PGC-1 , A Potential Therapeutic Target for Early Intervention in Parkinson's Disease
- (2010) B. Zheng et al. Science Translational Medicine
- Divergent roles of prokineticin receptors in the endothelial cells: angiogenesis and fenestration
- (2009) Célia Guilini et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Inhibition of Prolyl Hydroxylase Protects against 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Neurotoxicity
- (2009) Donna W. Lee et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Loss of PINK1 Function Promotes Mitophagy through Effects on Oxidative Stress and Mitochondrial Fission
- (2009) Ruben K. Dagda et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inactivation of neuronal forebrain A2Areceptors protects dopaminergic neurons in a mouse model of Parkinsonâs disease
- (2009) Anna R. Carta et al. JOURNAL OF NEUROCHEMISTRY
- Hypoxia-inducible factor 1: a new hope to counteract neurodegeneration?
- (2009) Sónia C. Correia et al. JOURNAL OF NEUROCHEMISTRY
- Region-specific changes in mitochondrial D-loop in aged rat CNS
- (2009) Simone C. McInerny et al. MECHANISMS OF AGEING AND DEVELOPMENT
- The MitoPark Mouse – An animal model of Parkinson's disease with impaired respiratory chain function in dopamine neurons
- (2009) Mats I. Ekstrand et al. PARKINSONISM & RELATED DISORDERS
- Efferent Projections of Prokineticin 2 Expressing Neurons in the Mouse Suprachiasmatic Nucleus
- (2009) Chengkang Zhang et al. PLoS One
- Prokineticin-signaling pathway
- (2008) Elly S.W. Ngan et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started